IBDEI03D ; ; 01-AUG-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8044,1,1,0)
 ;;=1^COMPREHENSIVE, MOD COMPLEX
 ;;^UTILITY(U,$J,358.3,8044,1,2,0)
 ;;=2^99344
 ;;^UTILITY(U,$J,358.3,8045,0)
 ;;=99345^^44^414^5
 ;;^UTILITY(U,$J,358.3,8045,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,8045,1,1,0)
 ;;=1^COMPREHENSIVE, HIGH COMPLEX
 ;;^UTILITY(U,$J,358.3,8045,1,2,0)
 ;;=2^99345
 ;;^UTILITY(U,$J,358.3,8046,0)
 ;;=99347^^44^415^1
 ;;^UTILITY(U,$J,358.3,8046,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,8046,1,1,0)
 ;;=1^PROBLEM FOCUSED VISIT
 ;;^UTILITY(U,$J,358.3,8046,1,2,0)
 ;;=2^99347
 ;;^UTILITY(U,$J,358.3,8047,0)
 ;;=99348^^44^415^2
 ;;^UTILITY(U,$J,358.3,8047,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,8047,1,1,0)
 ;;=1^EXPANDED PROBLEM FOCUSED 
 ;;^UTILITY(U,$J,358.3,8047,1,2,0)
 ;;=2^99348
 ;;^UTILITY(U,$J,358.3,8048,0)
 ;;=99349^^44^415^3
 ;;^UTILITY(U,$J,358.3,8048,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,8048,1,1,0)
 ;;=1^DETAILED VISIT
 ;;^UTILITY(U,$J,358.3,8048,1,2,0)
 ;;=2^99349
 ;;^UTILITY(U,$J,358.3,8049,0)
 ;;=99350^^44^415^4
 ;;^UTILITY(U,$J,358.3,8049,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,8049,1,1,0)
 ;;=1^COMPREHENSIVE VISIT
 ;;^UTILITY(U,$J,358.3,8049,1,2,0)
 ;;=2^99350
 ;;^UTILITY(U,$J,358.3,8050,0)
 ;;=99339^^44^415^5
 ;;^UTILITY(U,$J,358.3,8050,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,8050,1,1,0)
 ;;=1^Suprv Home Care or ALF 15-29 Min per Month
 ;;^UTILITY(U,$J,358.3,8050,1,2,0)
 ;;=2^99339
 ;;^UTILITY(U,$J,358.3,8051,0)
 ;;=99340^^44^415^6
 ;;^UTILITY(U,$J,358.3,8051,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,8051,1,1,0)
 ;;=1^Suprv Home Care or ALF 30+ Min per Month
 ;;^UTILITY(U,$J,358.3,8051,1,2,0)
 ;;=2^99340
 ;;^UTILITY(U,$J,358.3,8052,0)
 ;;=B18.2^^45^416^40
 ;;^UTILITY(U,$J,358.3,8052,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8052,1,3,0)
 ;;=3^Hepatitis C,Chr
 ;;^UTILITY(U,$J,358.3,8052,1,4,0)
 ;;=4^B18.2
 ;;^UTILITY(U,$J,358.3,8052,2)
 ;;=^5000548
 ;;^UTILITY(U,$J,358.3,8053,0)
 ;;=E11.9^^45^416^25
 ;;^UTILITY(U,$J,358.3,8053,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8053,1,3,0)
 ;;=3^Diabetes Type 2
 ;;^UTILITY(U,$J,358.3,8053,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,8053,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,8054,0)
 ;;=E11.40^^45^416^23
 ;;^UTILITY(U,$J,358.3,8054,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8054,1,3,0)
 ;;=3^DM Type 2 w/ Neuropathy
 ;;^UTILITY(U,$J,358.3,8054,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,8054,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,8055,0)
 ;;=E78.2^^45^416^41
 ;;^UTILITY(U,$J,358.3,8055,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8055,1,3,0)
 ;;=3^Hyperlipidemia,Mixed
 ;;^UTILITY(U,$J,358.3,8055,1,4,0)
 ;;=4^E78.2
 ;;^UTILITY(U,$J,358.3,8055,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,8056,0)
 ;;=E78.5^^45^416^42
 ;;^UTILITY(U,$J,358.3,8056,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8056,1,3,0)
 ;;=3^Hyperlipidemia,Unspec
 ;;^UTILITY(U,$J,358.3,8056,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,8056,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,8057,0)
 ;;=E66.3^^45^416^59
 ;;^UTILITY(U,$J,358.3,8057,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8057,1,3,0)
 ;;=3^Overweight
 ;;^UTILITY(U,$J,358.3,8057,1,4,0)
 ;;=4^E66.3
 ;;^UTILITY(U,$J,358.3,8057,2)
 ;;=^5002830
 ;;^UTILITY(U,$J,358.3,8058,0)
 ;;=F17.200^^45^416^52
 ;;^UTILITY(U,$J,358.3,8058,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8058,1,3,0)
 ;;=3^Nicotine Dependence,Unspec
 ;;^UTILITY(U,$J,358.3,8058,1,4,0)
 ;;=4^F17.200
 ;;^UTILITY(U,$J,358.3,8058,2)
 ;;=^5003360
 ;;^UTILITY(U,$J,358.3,8059,0)
 ;;=G43.909^^45^416^50
 ;;^UTILITY(U,$J,358.3,8059,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8059,1,3,0)
 ;;=3^Migraine,Unspec
 ;;^UTILITY(U,$J,358.3,8059,1,4,0)
 ;;=4^G43.909
 ;;^UTILITY(U,$J,358.3,8059,2)
 ;;=^5003909
 ;;^UTILITY(U,$J,358.3,8060,0)
 ;;=H91.93^^45^416^36
 ;;^UTILITY(U,$J,358.3,8060,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8060,1,3,0)
 ;;=3^Hearing Loss,Bilateral
 ;;^UTILITY(U,$J,358.3,8060,1,4,0)
 ;;=4^H91.93
 ;;^UTILITY(U,$J,358.3,8060,2)
 ;;=^5006944
 ;;^UTILITY(U,$J,358.3,8061,0)
 ;;=I10.^^45^416^43
 ;;^UTILITY(U,$J,358.3,8061,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8061,1,3,0)
 ;;=3^Hypertension
 ;;^UTILITY(U,$J,358.3,8061,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,8061,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,8062,0)
 ;;=I50.9^^45^416^19
 ;;^UTILITY(U,$J,358.3,8062,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8062,1,3,0)
 ;;=3^Congestive Heart Failure,Unspec
 ;;^UTILITY(U,$J,358.3,8062,1,4,0)
 ;;=4^I50.9
 ;;^UTILITY(U,$J,358.3,8062,2)
 ;;=^5007251
 ;;^UTILITY(U,$J,358.3,8063,0)
 ;;=I67.89^^45^416^18
 ;;^UTILITY(U,$J,358.3,8063,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8063,1,3,0)
 ;;=3^Cerebrovascular Disease,Oth
 ;;^UTILITY(U,$J,358.3,8063,1,4,0)
 ;;=4^I67.89
 ;;^UTILITY(U,$J,358.3,8063,2)
 ;;=^5007388
 ;;^UTILITY(U,$J,358.3,8064,0)
 ;;=J45.909^^45^416^4
 ;;^UTILITY(U,$J,358.3,8064,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8064,1,3,0)
 ;;=3^Asthma,Unspec,Uncomplicated
 ;;^UTILITY(U,$J,358.3,8064,1,4,0)
 ;;=4^J45.909
 ;;^UTILITY(U,$J,358.3,8064,2)
 ;;=^5008256
 ;;^UTILITY(U,$J,358.3,8065,0)
 ;;=J44.9^^45^416^16
 ;;^UTILITY(U,$J,358.3,8065,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8065,1,3,0)
 ;;=3^COPD,Unspec
 ;;^UTILITY(U,$J,358.3,8065,1,4,0)
 ;;=4^J44.9
 ;;^UTILITY(U,$J,358.3,8065,2)
 ;;=^5008241
 ;;^UTILITY(U,$J,358.3,8066,0)
 ;;=K21.9^^45^416^31
 ;;^UTILITY(U,$J,358.3,8066,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8066,1,3,0)
 ;;=3^GERD w/o Esophagitis
 ;;^UTILITY(U,$J,358.3,8066,1,4,0)
 ;;=4^K21.9
 ;;^UTILITY(U,$J,358.3,8066,2)
 ;;=^5008505
 ;;^UTILITY(U,$J,358.3,8067,0)
 ;;=N40.1^^45^416^29
 ;;^UTILITY(U,$J,358.3,8067,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8067,1,3,0)
 ;;=3^Enlarged Prostate w/ LUTS
 ;;^UTILITY(U,$J,358.3,8067,1,4,0)
 ;;=4^N40.1
 ;;^UTILITY(U,$J,358.3,8067,2)
 ;;=^5015690
 ;;^UTILITY(U,$J,358.3,8068,0)
 ;;=L03.818^^45^416^17
 ;;^UTILITY(U,$J,358.3,8068,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8068,1,3,0)
 ;;=3^Cellulitis,Oth Sites
 ;;^UTILITY(U,$J,358.3,8068,1,4,0)
 ;;=4^L03.818
 ;;^UTILITY(U,$J,358.3,8068,2)
 ;;=^5009064
 ;;^UTILITY(U,$J,358.3,8069,0)
 ;;=G47.33^^45^416^77
 ;;^UTILITY(U,$J,358.3,8069,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8069,1,3,0)
 ;;=3^Sleep Apnea,Obstructive
 ;;^UTILITY(U,$J,358.3,8069,1,4,0)
 ;;=4^G47.33
 ;;^UTILITY(U,$J,358.3,8069,2)
 ;;=^332763
 ;;^UTILITY(U,$J,358.3,8070,0)
 ;;=R73.01^^45^416^46
 ;;^UTILITY(U,$J,358.3,8070,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8070,1,3,0)
 ;;=3^Impaired Fasting Glucose
 ;;^UTILITY(U,$J,358.3,8070,1,4,0)
 ;;=4^R73.01
 ;;^UTILITY(U,$J,358.3,8070,2)
 ;;=^5019561
 ;;^UTILITY(U,$J,358.3,8071,0)
 ;;=R74.8^^45^416^1
 ;;^UTILITY(U,$J,358.3,8071,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8071,1,3,0)
 ;;=3^Abnormal Levels of Serum Enzymes
 ;;^UTILITY(U,$J,358.3,8071,1,4,0)
 ;;=4^R74.8
 ;;^UTILITY(U,$J,358.3,8071,2)
 ;;=^5019566
 ;;^UTILITY(U,$J,358.3,8072,0)
 ;;=R03.0^^45^416^27
 ;;^UTILITY(U,$J,358.3,8072,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8072,1,3,0)
 ;;=3^Elevated BP Reading w/o Diagnosis of HTN
 ;;^UTILITY(U,$J,358.3,8072,1,4,0)
 ;;=4^R03.0
 ;;^UTILITY(U,$J,358.3,8072,2)
 ;;=^5019171
 ;;^UTILITY(U,$J,358.3,8073,0)
 ;;=Z91.19^^45^416^53
 ;;^UTILITY(U,$J,358.3,8073,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8073,1,3,0)
 ;;=3^Noncompliance w/ Medical Treatment/Regimen
 ;;^UTILITY(U,$J,358.3,8073,1,4,0)
 ;;=4^Z91.19
 ;;^UTILITY(U,$J,358.3,8073,2)
 ;;=^5063618
 ;;^UTILITY(U,$J,358.3,8074,0)
 ;;=E66.01^^45^416^54
 ;;^UTILITY(U,$J,358.3,8074,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8074,1,3,0)
 ;;=3^Obesity,Morbid
 ;;^UTILITY(U,$J,358.3,8074,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,8074,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,8075,0)
 ;;=F43.11^^45^416^61
 ;;^UTILITY(U,$J,358.3,8075,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8075,1,3,0)
 ;;=3^PTSD,Acute
 ;;^UTILITY(U,$J,358.3,8075,1,4,0)
 ;;=4^F43.11
 ;;^UTILITY(U,$J,358.3,8075,2)
 ;;=^5003571
 ;;^UTILITY(U,$J,358.3,8076,0)
 ;;=F43.12^^45^416^62
 ;;^UTILITY(U,$J,358.3,8076,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8076,1,3,0)
 ;;=3^PTSD,Chronic
 ;;^UTILITY(U,$J,358.3,8076,1,4,0)
 ;;=4^F43.12
 ;;^UTILITY(U,$J,358.3,8076,2)
 ;;=^5003572
 ;;^UTILITY(U,$J,358.3,8077,0)
 ;;=I25.119^^45^416^5
 ;;^UTILITY(U,$J,358.3,8077,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8077,1,3,0)
 ;;=3^Athscl Hrt Dis of Native Cor Art w/ Ang Pctrs,Unspec
 ;;^UTILITY(U,$J,358.3,8077,1,4,0)
 ;;=4^I25.119
 ;;^UTILITY(U,$J,358.3,8077,2)
 ;;=^5007111
 ;;^UTILITY(U,$J,358.3,8078,0)
 ;;=I25.10^^45^416^6
 ;;^UTILITY(U,$J,358.3,8078,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8078,1,3,0)
 ;;=3^Athscl Hrt Dis of Native Cor Art w/o Ang Pctrs
 ;;^UTILITY(U,$J,358.3,8078,1,4,0)
 ;;=4^I25.10
 ;;^UTILITY(U,$J,358.3,8078,2)
 ;;=^5007107
 ;;^UTILITY(U,$J,358.3,8079,0)
 ;;=F17.219^^45^416^51
 ;;^UTILITY(U,$J,358.3,8079,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8079,1,3,0)
 ;;=3^Nicotine Dependence,Cigarettes
 ;;^UTILITY(U,$J,358.3,8079,1,4,0)
 ;;=4^F17.219
 ;;^UTILITY(U,$J,358.3,8079,2)
 ;;=^5003369
 ;;^UTILITY(U,$J,358.3,8080,0)
 ;;=Z51.5^^45^416^64
 ;;^UTILITY(U,$J,358.3,8080,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8080,1,3,0)
 ;;=3^Palliative Care Encounter
 ;;^UTILITY(U,$J,358.3,8080,1,4,0)
 ;;=4^Z51.5
 ;;^UTILITY(U,$J,358.3,8080,2)
 ;;=^5063063
 ;;^UTILITY(U,$J,358.3,8081,0)
 ;;=Z23.^^45^416^28
 ;;^UTILITY(U,$J,358.3,8081,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8081,1,3,0)
 ;;=3^Encounter for Immunization(s)
 ;;^UTILITY(U,$J,358.3,8081,1,4,0)
 ;;=4^Z23.
 ;;^UTILITY(U,$J,358.3,8081,2)
 ;;=^5062795
 ;;^UTILITY(U,$J,358.3,8082,0)
 ;;=E11.65^^45^416^20
 ;;^UTILITY(U,$J,358.3,8082,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8082,1,3,0)
 ;;=3^DM Type 2 Uncontrolled w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,8082,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,8082,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,8083,0)
 ;;=E11.649^^45^416^21
 ;;^UTILITY(U,$J,358.3,8083,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8083,1,3,0)
 ;;=3^DM Type 2 Uncontrolled w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,8083,1,4,0)
 ;;=4^E11.649
 ;;^UTILITY(U,$J,358.3,8083,2)
 ;;=^5002662
 ;;^UTILITY(U,$J,358.3,8084,0)
 ;;=I16.0^^45^416^44
 ;;^UTILITY(U,$J,358.3,8084,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8084,1,3,0)
 ;;=3^Hypertensive Urgency
 ;;^UTILITY(U,$J,358.3,8084,1,4,0)
 ;;=4^I16.0
 ;;^UTILITY(U,$J,358.3,8084,2)
 ;;=^8133013
 ;;^UTILITY(U,$J,358.3,8085,0)
 ;;=H54.8^^45^416^47
 ;;^UTILITY(U,$J,358.3,8085,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8085,1,3,0)
 ;;=3^Legal Blindness,USA Definition
 ;;^UTILITY(U,$J,358.3,8085,1,4,0)
 ;;=4^H54.8
 ;;^UTILITY(U,$J,358.3,8085,2)
 ;;=^5006369
 ;;^UTILITY(U,$J,358.3,8086,0)
 ;;=F10.10^^45^416^2
 ;;^UTILITY(U,$J,358.3,8086,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8086,1,3,0)
 ;;=3^Alcohol Abuse,Uncomplicated
 ;;^UTILITY(U,$J,358.3,8086,1,4,0)
 ;;=4^F10.10
 ;;^UTILITY(U,$J,358.3,8086,2)
 ;;=^5003068
 ;;^UTILITY(U,$J,358.3,8087,0)
 ;;=J30.9^^45^416^3
 ;;^UTILITY(U,$J,358.3,8087,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8087,1,3,0)
 ;;=3^Allergic Rhinitis,Unspec
 ;;^UTILITY(U,$J,358.3,8087,1,4,0)
 ;;=4^J30.9
 ;;^UTILITY(U,$J,358.3,8087,2)
 ;;=^5008205
 ;;^UTILITY(U,$J,358.3,8088,0)
 ;;=I48.0^^45^416^7
 ;;^UTILITY(U,$J,358.3,8088,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8088,1,3,0)
 ;;=3^Atrial Fibrillation Paroxysmal (PAF)
 ;;^UTILITY(U,$J,358.3,8088,1,4,0)
 ;;=4^I48.0
 ;;^UTILITY(U,$J,358.3,8088,2)
 ;;=^90473
 ;;^UTILITY(U,$J,358.3,8089,0)
 ;;=N18.1^^45^416^9
 ;;^UTILITY(U,$J,358.3,8089,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8089,1,3,0)
 ;;=3^CKD,Stage 1
 ;;^UTILITY(U,$J,358.3,8089,1,4,0)
 ;;=4^N18.1
 ;;^UTILITY(U,$J,358.3,8089,2)
 ;;=^5015602
 ;;^UTILITY(U,$J,358.3,8090,0)
 ;;=N18.2^^45^416^10
 ;;^UTILITY(U,$J,358.3,8090,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8090,1,3,0)
 ;;=3^CKD,Stage 2
 ;;^UTILITY(U,$J,358.3,8090,1,4,0)
 ;;=4^N18.2
 ;;^UTILITY(U,$J,358.3,8090,2)
 ;;=^5015603
 ;;^UTILITY(U,$J,358.3,8091,0)
 ;;=N18.4^^45^416^14
 ;;^UTILITY(U,$J,358.3,8091,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8091,1,3,0)
 ;;=3^CKD,Stage 4
 ;;^UTILITY(U,$J,358.3,8091,1,4,0)
 ;;=4^N18.4
 ;;^UTILITY(U,$J,358.3,8091,2)
 ;;=^5015605
 ;;^UTILITY(U,$J,358.3,8092,0)
 ;;=N18.5^^45^416^15
 ;;^UTILITY(U,$J,358.3,8092,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8092,1,3,0)
 ;;=3^CKD,Stage 5
 ;;^UTILITY(U,$J,358.3,8092,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,8092,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,8093,0)
 ;;=N18.6^^45^416^26
 ;;^UTILITY(U,$J,358.3,8093,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8093,1,3,0)
 ;;=3^ESRD
 ;;^UTILITY(U,$J,358.3,8093,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,8093,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,8094,0)
 ;;=E11.22^^45^416^22
 ;;^UTILITY(U,$J,358.3,8094,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8094,1,3,0)
 ;;=3^DM Type 2 w/ CKD
 ;;^UTILITY(U,$J,358.3,8094,1,4,0)
 ;;=4^E11.22
 ;;^UTILITY(U,$J,358.3,8094,2)
 ;;=^5002630
 ;;^UTILITY(U,$J,358.3,8095,0)
 ;;=E11.319^^45^416^24
 ;;^UTILITY(U,$J,358.3,8095,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8095,1,3,0)
 ;;=3^DM Type 2 w/ Retinopathy Unspec w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,8095,1,4,0)
 ;;=4^E11.319
 ;;^UTILITY(U,$J,358.3,8095,2)
 ;;=^5002633
 ;;^UTILITY(U,$J,358.3,8096,0)
 ;;=G40.909^^45^416^76
 ;;^UTILITY(U,$J,358.3,8096,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8096,1,3,0)
 ;;=3^Seizure Disorder NOS
 ;;^UTILITY(U,$J,358.3,8096,1,4,0)
 ;;=4^G40.909
 ;;^UTILITY(U,$J,358.3,8096,2)
 ;;=^5003865
 ;;^UTILITY(U,$J,358.3,8097,0)
 ;;=N52.9^^45^416^30
 ;;^UTILITY(U,$J,358.3,8097,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8097,1,3,0)
 ;;=3^Erectile Dysfuntion,Unspec
 ;;^UTILITY(U,$J,358.3,8097,1,4,0)
 ;;=4^N52.9
 ;;^UTILITY(U,$J,358.3,8097,2)
 ;;=^5015763
 ;;^UTILITY(U,$J,358.3,8098,0)
 ;;=I50.22^^45^416^39
 ;;^UTILITY(U,$J,358.3,8098,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8098,1,3,0)
 ;;=3^Heart Failure,Systolic,Chronic
 ;;^UTILITY(U,$J,358.3,8098,1,4,0)
 ;;=4^I50.22
 ;;^UTILITY(U,$J,358.3,8098,2)
 ;;=^5007241
 ;;^UTILITY(U,$J,358.3,8099,0)
 ;;=I50.32^^45^416^37
 ;;^UTILITY(U,$J,358.3,8099,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8099,1,3,0)
 ;;=3^Heart Failure,Diastolic,Chronic
 ;;^UTILITY(U,$J,358.3,8099,1,4,0)
 ;;=4^I50.32
 ;;^UTILITY(U,$J,358.3,8099,2)
 ;;=^5007245
 ;;^UTILITY(U,$J,358.3,8100,0)
 ;;=I50.42^^45^416^38
 ;;^UTILITY(U,$J,358.3,8100,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8100,1,3,0)
 ;;=3^Heart Failure,Systolic & Diastolic,Chronic
 ;;^UTILITY(U,$J,358.3,8100,1,4,0)
 ;;=4^I50.42
 ;;^UTILITY(U,$J,358.3,8100,2)
 ;;=^5007249
 ;;^UTILITY(U,$J,358.3,8101,0)
 ;;=I13.0^^45^416^32
 ;;^UTILITY(U,$J,358.3,8101,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8101,1,3,0)
 ;;=3^HTN Hrt & CKD w/ Hrt Fail w/ Stage 1-4 Chr Kdny
 ;;^UTILITY(U,$J,358.3,8101,1,4,0)
 ;;=4^I13.0
 ;;^UTILITY(U,$J,358.3,8101,2)
 ;;=^5007067
 ;;^UTILITY(U,$J,358.3,8102,0)
 ;;=I13.2^^45^416^33
 ;;^UTILITY(U,$J,358.3,8102,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8102,1,3,0)
 ;;=3^HTN Hrt & CKD w/ Hrt Fail w/ Stage 5 Chr Kdny
 ;;^UTILITY(U,$J,358.3,8102,1,4,0)
 ;;=4^I13.2
 ;;^UTILITY(U,$J,358.3,8102,2)
 ;;=^5007070
 ;;^UTILITY(U,$J,358.3,8103,0)
 ;;=I13.10^^45^416^34
 ;;^UTILITY(U,$J,358.3,8103,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8103,1,3,0)
 ;;=3^HTN Hrt & CKD w/o Hrt Fail w/ Stage 1-4 Chr Kdny
 ;;^UTILITY(U,$J,358.3,8103,1,4,0)
 ;;=4^I13.10
 ;;^UTILITY(U,$J,358.3,8103,2)
 ;;=^5007068
 ;;^UTILITY(U,$J,358.3,8104,0)
 ;;=I13.11^^45^416^35
 ;;^UTILITY(U,$J,358.3,8104,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8104,1,3,0)
 ;;=3^HTN Hrt & CKD w/o Hrt Fail w/ Stage 5 Chr Kdny
 ;;^UTILITY(U,$J,358.3,8104,1,4,0)
 ;;=4^I13.11
 ;;^UTILITY(U,$J,358.3,8104,2)
 ;;=^5007069
 ;;^UTILITY(U,$J,358.3,8105,0)
 ;;=E03.9^^45^416^45
 ;;^UTILITY(U,$J,358.3,8105,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8105,1,3,0)
 ;;=3^Hypothyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,8105,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,8105,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,8106,0)
 ;;=C61.^^45^416^49
 ;;^UTILITY(U,$J,358.3,8106,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8106,1,3,0)
 ;;=3^Malig Neopl Prostate
 ;;^UTILITY(U,$J,358.3,8106,1,4,0)
 ;;=4^C61.
 ;;^UTILITY(U,$J,358.3,8106,2)
 ;;=^267239
 ;;^UTILITY(U,$J,358.3,8107,0)
 ;;=F11.20^^45^416^55
 ;;^UTILITY(U,$J,358.3,8107,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8107,1,3,0)
 ;;=3^Opioid Dependence,Uncomplicated
 ;;^UTILITY(U,$J,358.3,8107,1,4,0)
 ;;=4^F11.20
 ;;^UTILITY(U,$J,358.3,8107,2)
 ;;=^5003127
 ;;^UTILITY(U,$J,358.3,8108,0)
 ;;=M19.90^^45^416^56
 ;;^UTILITY(U,$J,358.3,8108,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8108,1,3,0)
 ;;=3^Osteoarthritis,Unspec
 ;;^UTILITY(U,$J,358.3,8108,1,4,0)
 ;;=4^M19.90
 ;;^UTILITY(U,$J,358.3,8108,2)
 ;;=^5010853
 ;;^UTILITY(U,$J,358.3,8109,0)
 ;;=M85.80^^45^416^57
 ;;^UTILITY(U,$J,358.3,8109,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8109,1,3,0)
 ;;=3^Osteopenia,Unspec Site
 ;;^UTILITY(U,$J,358.3,8109,1,4,0)
 ;;=4^M85.80
 ;;^UTILITY(U,$J,358.3,8109,2)
 ;;=^5014473
 ;;^UTILITY(U,$J,358.3,8110,0)
 ;;=M81.0^^45^416^58
 ;;^UTILITY(U,$J,358.3,8110,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8110,1,3,0)
 ;;=3^Osteoporosis,Age-Related w/o Fx
 ;;^UTILITY(U,$J,358.3,8110,1,4,0)
 ;;=4^M81.0
 ;;^UTILITY(U,$J,358.3,8110,2)
 ;;=^5013555
 ;;^UTILITY(U,$J,358.3,8111,0)
 ;;=I73.9^^45^416^65
 ;;^UTILITY(U,$J,358.3,8111,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8111,1,3,0)
 ;;=3^Peripheral Vascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,8111,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,8111,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,8112,0)
 ;;=R21.^^45^416^68
 ;;^UTILITY(U,$J,358.3,8112,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8112,1,3,0)
 ;;=3^Rash
 ;;^UTILITY(U,$J,358.3,8112,1,4,0)
 ;;=4^R21.
 ;;^UTILITY(U,$J,358.3,8112,2)
 ;;=^5019283
 ;;^UTILITY(U,$J,358.3,8113,0)
 ;;=Z12.11^^45^416^73
 ;;^UTILITY(U,$J,358.3,8113,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8113,1,3,0)
 ;;=3^Screening,Colon CA
 ;;^UTILITY(U,$J,358.3,8113,1,4,0)
 ;;=4^Z12.11
 ;;^UTILITY(U,$J,358.3,8113,2)
 ;;=^5062681
 ;;^UTILITY(U,$J,358.3,8114,0)
 ;;=Z12.39^^45^416^71
 ;;^UTILITY(U,$J,358.3,8114,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8114,1,3,0)
 ;;=3^Screening,Breast CA
 ;;^UTILITY(U,$J,358.3,8114,1,4,0)
 ;;=4^Z12.39
 ;;^UTILITY(U,$J,358.3,8114,2)
 ;;=^5062686
 ;;^UTILITY(U,$J,358.3,8115,0)
 ;;=Z12.4^^45^416^72
 ;;^UTILITY(U,$J,358.3,8115,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8115,1,3,0)
 ;;=3^Screening,Cervical CA
 ;;^UTILITY(U,$J,358.3,8115,1,4,0)
 ;;=4^Z12.4
 ;;^UTILITY(U,$J,358.3,8115,2)
 ;;=^5062687
 ;;^UTILITY(U,$J,358.3,8116,0)
 ;;=Z13.6^^45^416^70
 ;;^UTILITY(U,$J,358.3,8116,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8116,1,3,0)
 ;;=3^Screening,AAA
 ;;^UTILITY(U,$J,358.3,8116,1,4,0)
 ;;=4^Z13.6
 ;;^UTILITY(U,$J,358.3,8116,2)
 ;;=^5062707
 ;;^UTILITY(U,$J,358.3,8117,0)
 ;;=Z11.3^^45^416^75
 ;;^UTILITY(U,$J,358.3,8117,1,0)
 ;;=^358.31IA^4^2
